Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06284317
What this trial is testing

Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
ETOP IBCSG Partners Foundation 290
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06962189
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study

Who this might be right for
Non Small Cell Lung Cancer (Stage III)
Zhejiang University 39
Early research (Phase 1)Ended earlyNCT01282333
What this trial is testing

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+11 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00075426
What this trial is testing

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The University of Texas Medical Branch, Galveston 30
Testing effectiveness (Phase 2)Study completedNCT00086333
What this trial is testing

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung Carcinoma
Seagen Inc. 30
Large-scale testing (Phase 3)Ended earlyNCT00801736
What this trial is testing

ERCC1 Targeted Trial

Who this might be right for
Lung Cancer
University College, London 648
Testing effectiveness (Phase 2)Study completedNCT00057798
What this trial is testing

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00005849
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Chicago 15
Testing effectiveness (Phase 2)WithdrawnNCT03699033
What this trial is testing

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Stephanie Smiddy
Testing effectiveness (Phase 2)Ended earlyNCT00063258
What this trial is testing

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785584
What this trial is testing

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

Who this might be right for
ALK-positive Advanced NSCLCALK-positive Non-small Cell Lung Cancer (NSCLC)MPR+1 more
Fujian Medical University Union Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00247416
What this trial is testing

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Susanne Arnold 60
Testing effectiveness (Phase 2)Study completedNCT00094835
What this trial is testing

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 51
Early research (Phase 1)WithdrawnNCT01971489
What this trial is testing

Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmRecurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung Cancer+2 more
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00088959
What this trial is testing

Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00850785
What this trial is testing

Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Providence Health & Services 6
Testing effectiveness (Phase 2)UnknownNCT00453115
What this trial is testing

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
National Cancer Center, Korea 43
Large-scale testing (Phase 3)Study completedNCT00257608
What this trial is testing

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 1,145
Testing effectiveness (Phase 2)Study completedNCT00005091
What this trial is testing

DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Daiichi Pharmaceuticals
Not applicableNot Yet RecruitingNCT05988697
What this trial is testing

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

Who this might be right for
NSCLCBRAF V600E MutationAdvanced Cancer+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 36
Next Page